A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors | MicrobiomeTrials← Back to trialsNCT05765851
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2023-05-30Est. Completion: 2030-05-15
Enrollment target: 108 participants Locations- Florida Cancer Specialists, Sarasota, Florida, United States
- Lifespan Cancer Institute, Providence, Rhode Island, United States
- University of Utah, Salt Lake City, Utah, United States
- NEXT Oncology, Fairfax, Virginia, United States
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
- Oncopole - Institut Claudius Regaud, Toulouse, Haute Garonne, France
- Centre Léon Bérard, Lyon, Rhone, France
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
Other microbiome trials you might be interested in
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell CarcinomaLocally Recurrent Hypopharyngeal Squamous Cell CarcinomaLocally Recurrent Laryngeal Squamous Cell CarcinomaLocally Recurrent Oral Cavity Squamous Cell CarcinomaLocally Recurrent Oropharyngeal Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell Carcinoma
Metastatic Melanoma
Metastatic Oral Cavity Squamous Cell Carcinoma
Metastatic Oropharyngeal Squamous Cell Carcinoma
Recurrent Melanoma
Stage III Hypopharyngeal Carcinoma AJCC v8
Stage III Laryngeal Cancer AJCC v8
Stage III Lip and Oral Cavity Cancer AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IV Hypopharyngeal Carcinoma AJCC v8
Stage IV Laryngeal Cancer AJCC v8
Stage IV Lip and Oral Cavity Cancer AJCC v8
Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Unresectable Melanoma
This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in tr…
Phoenix, United StatesEst. completion Jan 1, 2027
Advanced Solid TumorsMalignant Neoplasm
Researchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has s…
Birmingham, United StatesEst. completion Oct 25, 2028
Solid Tumors
This is a prospective, single-center, open-label clinical study comparing the imaging performance of INR202 PET/CT versu…
Multiple LocationsEst. completion Jul 2028